CSF1R and amyloidosis: Moreover, other study reported that 5.5-month administration of PLX5562, a CSF1R inhibitor, to 5xFAD mice at 1.5 months of age prevented the amyloid plaque formation but had no beneficial effect on hippocampal dependent memory [17].